Literature DB >> 15296029

Mitral valve replacement after percutaneous transluminal mitral commissurotomy.

Makoto Kamada1, Kenji Ohsaka, Susumu Nagamine, Hidemitsu Kakihata.   

Abstract

OBJECTIVES: We reviewed our experience of mitral valve replacement (MVR) after percutaneous transluminal mitral commissurotomy (PTMC) for mitral stenosis (MS).
METHODS: From December 1987 to December 2001, PTMC was conducted in 75 patients with symptomatic rheumatic MS. At mean follow-up of 8.4+/-3.5 years, 11 patients (14.7%) underwent MVR for mitral restenosis (9 cases) and mitral regurgitation (MR) (2 cases). The mean interval between PTMC and MVR was 5.2+/-3.2 years.
RESULTS: There were 2 hospital deaths (due to low output syndrome and mediastinitis) and 2 complications (prosthetic valve endocarditis and left ventricular rupture). The mitral valve area (MVA) at pre-PTMC, post-PTMC and pre-MVR was 1.02+/-0.48 cm2, 1.55+/-0.59 cm2, 1.04+/-0.23 cm2, respectively. The MVA significantly increased after PTMC (p<0.01), but decreased significantly to the pre-PTMC value at pre-MVR (p<0.05). The left atrial dimension (LAD) significantly increased from 50.4+/-10.8 mm at pre-PTMC to 61.1+/-13.1 mm at pre-MVR (p<0.05). The number of significant tricuspid regurgitation (TR) cases increased from 2 at pre-PTMC to 5 at pre-MVR. The New York Heart Association class got better after PTMC (3 cases in class III at pre-PTMC to 0 at post-PTMC), but at pre-MVR, deteriorated to the same level at pre-PTMC (4 cases in class III).
CONCLUSIONS: Our results of MVR after PTMC were reasonable to be considered despite their high risk at MVR resulting in 2 hospital deaths. For the reliable relief of MS and control of TR, not PTMC but MVR combined with tricuspid annuloplasty may be preferable in such two cases suffering from congestive heart failure with significant TR at first intervention. Close follow-ups like periodic ultrasonic cardiography studies should be conducted to gain more information on the mitral restenosis, TR deterioration and dilatation of the cardiac chambers.

Entities:  

Mesh:

Year:  2004        PMID: 15296029     DOI: 10.1007/s11748-004-0065-4

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  6 in total

1.  Mitral valve operation after percutaneous transvenous mitral commissurotomy (PTMC): an evaluation of PTMC indications based on intraoperative findings.

Authors:  T Abe; T Mawatari; N Takahashi; J Sakata; R Urita; S Komatsu
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Ten-years clinical follow-up following successful percutaneous transvenous mitral commissurotomy: single-center experience.

Authors:  N Hamasaki; H Nosaka; T Kimura; Y Nakagawa; H Yokoi; M Iwabuchi; T Tamura; M Nobuyoshi
Journal:  Catheter Cardiovasc Interv       Date:  2000-03       Impact factor: 2.692

3.  Long-term clinical and echocardiographic outcome in patients with mitral stenosis treated with percutaneous transvenous mitral commissurotomy.

Authors:  F Saeki; Y Ishizaka; T Tamura
Journal:  Jpn Circ J       Date:  1999-08

Review 4.  Complications related to percutaneous transvenous mitral commissurotomy.

Authors:  J K Harrison; J S Wilson; S E Hearne; T M Bashore
Journal:  Cathet Cardiovasc Diagn       Date:  1994

5.  Clinical follow-up of patients undergoing percutaneous mitral balloon valvotomy.

Authors:  I F Palacios; M E Tuzcu; A E Weyman; J B Newell; P C Block
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

6.  Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease.

Authors:  Y Kosakai; A T Kawaguchi; F Isobe; Y Sasako; K Nakano; K Eishi; N Tanaka; Y Kito; Y Kawashima
Journal:  J Thorac Cardiovasc Surg       Date:  1994-12       Impact factor: 5.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.